Game Plan Financial Advisors, LLC V Tv Therapeutics Inc. Transaction History

Game Plan Financial Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.69 $12,350 - $21,970	-13,000 Closed	0 $0
Q2 2021 Jul 14, 2021	SELL	$2.27 - $3.44 $4,540 - $6,880	-2,000 Reduced 13.33%	13,000 $30,000
Q1 2021 Apr 28, 2021	BUY	$1.97 - $2.89 $29,550 - $43,350	15,000 New	15,000 $41,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.